Showing 1 - 15 results of 15 for search '"integrated screening"', 查詢時間: 0.02s Refine Results
  1. 1
    2D–shear-wave elastography example: non-MAFLD CKD case (male, 54 years).

    2D–shear-wave elastography example: non-MAFLD CKD case (male, 54 years). 由 Zienab M. Saad (22676502)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  2. 2
    2D–shear-wave elastography example: MAFLD + CKD case (male, 65 years).

    2D–shear-wave elastography example: MAFLD + CKD case (male, 65 years). 由 Zienab M. Saad (22676502)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  3. 3
    eGFR in the study participants.

    eGFR in the study participants. 由 Zienab M. Saad (22676502)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  4. 4
    Demographic and Clinical Characteristics of Study Participants.

    Demographic and Clinical Characteristics of Study Participants. 由 Zienab M. Saad (22676502)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  5. 5
    Stratification of Liver Stiffness according to eGFR in the MAFLD group.

    Stratification of Liver Stiffness according to eGFR in the MAFLD group. 由 Zienab M. Saad (22676502)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  6. 6
    Medication-inclusive multivariable logistic regression for MAFLD.

    Medication-inclusive multivariable logistic regression for MAFLD. 由 Zienab M. Saad (22676502)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  7. 7
    Receiver operating characteristic (ROC) curve analysis comparing the performance of non-invasive fibrosis scores in MAFLD patients.

    Receiver operating characteristic (ROC) curve analysis comparing the performance of non-invasive fibrosis scores in MAFLD patients. 由 Zienab M. Saad (22676502)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  8. 8
    Comparison of Non-invasive Liver Fibrosis Scores.

    Comparison of Non-invasive Liver Fibrosis Scores. 由 Zienab M. Saad (22676502)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  9. 9
    A. Violin plots showing eGFR distribution in MAFLD (red) vs. non-MAFLD (blue) groups.

    A. Violin plots showing eGFR distribution in MAFLD (red) vs. non-MAFLD (blue) groups. 由 Zienab M. Saad (22676502)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  10. 10
    Proposed pathophysiological crosstalk between MAFLD and CKD.

    Proposed pathophysiological crosstalk between MAFLD and CKD. 由 Zienab M. Saad (22676502)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  11. 11
    Liver Stiffness and Fibrosis Grading by MAFLD Status.

    Liver Stiffness and Fibrosis Grading by MAFLD Status. 由 Zienab M. Saad (22676502)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  12. 12
    2D–shear-wave elastography example: MAFLD + CKD case (female, 57 years).

    2D–shear-wave elastography example: MAFLD + CKD case (female, 57 years). 由 Zienab M. Saad (22676502)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  13. 13
    Grades of liver fibrosis in MAFLD group (grey) and non-MAFLD group (black).

    Grades of liver fibrosis in MAFLD group (grey) and non-MAFLD group (black). 由 Zienab M. Saad (22676502)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  14. 14
    Multivariable logistic regression models for MAFLD predictors.

    Multivariable logistic regression models for MAFLD predictors. 由 Zienab M. Saad (22676502)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  15. 15
    Liver Fibrosis Characteristics by CKD Stage in MAFLD Patients (n = 64).

    Liver Fibrosis Characteristics by CKD Stage in MAFLD Patients (n = 64). 由 Zienab M. Saad (22676502)

    出版 2025
    主題:
    加到收藏夾
    Saved in:

檢索工具: